Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.42 | N/A |
| PEG Ratio (TTM) | -0.40 | N/A |
| P/S Ratio (TTM) | 0.48 | N/A |
| P/B Ratio (TTM) | 1.17 | N/A |
| P/FCF Ratio (TTM) | 12.50 | N/A |
| Price to 5YR AVG Earnings Ratio | 5.77 | N/A |
| Price to 5YR AVG FCF Ratio | 6.10 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.06% | N/A |
| ROE (TTM) | 8.70% | N/A |
| Net Profit Margin (TTM) | 3.57% | N/A |
| ROIC 5YR AVG | 21.11% | N/A |
Growth (65%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -2.80% | 73.73% | 40.39% |
| Revenue | -5.37% | 8.91% | 2.49% |
| Net Income | -0.02% | 65.39% | 31.52% |
| Cash Flow | 73.06% | 23.36% | 22.62% |
Health (86%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.82 | N/A |
| Quick Ratio (TTM) | 1.17 | N/A |
| D/E Ratio (TTM) | 0.12 | N/A |
| Interest Coverage (TTM) | 22.93 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 3.02 | N/A |
| LTL to 5YR AVG FCF | 3.05 | N/A |
| Shares Outstanding Growth 5YR AVG | -5.96% | N/A |